Table 1: Characteristics of Exercise Trials (Cycling or Walking) in HFpEF Patients.
Study | N (Intervention/Control) | EF/NYHA Class | Session Time/Frequency/Intensity/Duration | Major Exclusion Criteria | Training Modality | Control | Outcomes (Cardiac Structure/Function) | Outcomes (Exercise Capacity) |
---|---|---|---|---|---|---|---|---|
Kitzman et al. 2010[27] | 26/27 | ≥50% II–III |
1 h/ Three times a week/~70% of HR reserve/16 weeks |
CAD, pulmonary disease, renal dysfunction (creatinine >2.5 mg/dl) | Walking/cycling | Attention control telephone call | E/A, DT, EF, LVEDV, LV mass | Peak VO2, 6MWD |
Edelmann et al. 2011[43] | 46/21 | ≥50% II–III |
20–40 min/ Two to three times a week/~60% of peak VO2/24 weeks | Pulmonary disease, CAD, anaemia | Cycling + resistance training | Usual care (maintenance of usual activity level) | E/e’, e’, EF, LVEDV LV mass | Peak VO2, 6MWD |
Smart et al. 2012[44] | 16/14 | >45% II–III |
30 min/ Three times a week/ ~70% of peak VO2/ 16 weeks | CAD | Cycling | Usual care (maintenance of usual activity level) | E/A, DT, E/e’, e’, EF | Peak VO2 |
Alves et al. 2012[45] | 20/11 | >55% NR |
30 min/ Three times a week/ ~75% of maximal HR/ 24 weeks | ACS, uncontrolled metabolic disease | Treadmill/ cycling | Usual care | E/A, EF | NR |
Kitzman et al. 2013[29] | 32/31 | ≥50% II–III |
1 h/ Three times a week/ ~70% of HR reserve/ 16 weeks | CAD, pulmonary disease, anaemia | Walking/ cycling | Attention control telephone call | E/A, DT, EF, LVEDV | Peak VO2, 6MWD |
Kitzman et al. 2016[46] | 51/49 | ≥50% II–III |
1 h/ Three times a week/ ~70% of HR reserve/ 20 weeks | As above | Walking | Attention control telephone call or caloric restriction | E/A, E/e’, e’, EF, LVEDV, LV mass | Peak VO2, 6MWD |
Fu et al. 2016[47] | 30/30 | ≥50% II–III |
30 min/ Three times a week/ 80% of peak VO2/ 12 weeks | AF, recent (<4 weeks) ACS or coronary revascularisation, COPD, renal dysfunction (eGFR <30 ml/min) | Cycling | Usual care | E/e’, EF | NR |
6MWD = 6-minute walk distance; ACS = acute coronary syndrome; CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease; DT = E-wave deceleration time; eGFR = estimated glomerular filtration rate; E/A; the ratio of peak early to late diastolic mitral inflow velocities; E/e’ = the ratio of early diastolic mitral inflow to annular velocities; e’ = early diastolic mitral annular velocity; EDV = end-diastolic volume; EF = ejection fraction; HFpEF = heart failure with preserved EF; HR = heart rate; LV = left ventricular; NR = not reported; NYHA = New York Heart Association; peak VO2 = peak exercise oxygen uptake.